Life threatening liver disease during treatment with monoclonal antibodies.
Publication
, Journal Article
Kaiser, T; Moessner, J; Patel, K; McHutchison, JG; Tillmann, HL
Published in: BMJ
February 18, 2009
Duke Scholars
Published In
BMJ
DOI
EISSN
1756-1833
Publication Date
February 18, 2009
Volume
338
Start / End Page
b508
Location
England
Related Subject Headings
- Recurrence
- Psoriasis
- Male
- Jaundice
- Immunosuppressive Agents
- Humans
- Hepatitis B, Chronic
- General & Internal Medicine
- Critical Illness
- Chemical and Drug Induced Liver Injury, Chronic
Citation
APA
Chicago
ICMJE
MLA
NLM
Kaiser, T., Moessner, J., Patel, K., McHutchison, J. G., & Tillmann, H. L. (2009). Life threatening liver disease during treatment with monoclonal antibodies. BMJ, 338, b508. https://doi.org/10.1136/bmj.b508
Kaiser, Thorsten, Joachim Moessner, Keyur Patel, John G. McHutchison, and Hans L. Tillmann. “Life threatening liver disease during treatment with monoclonal antibodies.” BMJ 338 (February 18, 2009): b508. https://doi.org/10.1136/bmj.b508.
Kaiser T, Moessner J, Patel K, McHutchison JG, Tillmann HL. Life threatening liver disease during treatment with monoclonal antibodies. BMJ. 2009 Feb 18;338:b508.
Kaiser, Thorsten, et al. “Life threatening liver disease during treatment with monoclonal antibodies.” BMJ, vol. 338, Feb. 2009, p. b508. Pubmed, doi:10.1136/bmj.b508.
Kaiser T, Moessner J, Patel K, McHutchison JG, Tillmann HL. Life threatening liver disease during treatment with monoclonal antibodies. BMJ. 2009 Feb 18;338:b508.
Published In
BMJ
DOI
EISSN
1756-1833
Publication Date
February 18, 2009
Volume
338
Start / End Page
b508
Location
England
Related Subject Headings
- Recurrence
- Psoriasis
- Male
- Jaundice
- Immunosuppressive Agents
- Humans
- Hepatitis B, Chronic
- General & Internal Medicine
- Critical Illness
- Chemical and Drug Induced Liver Injury, Chronic